Progyny, Inc. (PGNY) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $9.00K; Additional Paid in Capital, Common StockUSD $735.42M; Treasury Stock, Common, ValueUSD $537.52M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $245.00K.
- 2026-03-31: Common Stock, Value, IssuedUSD $9.00K; Additional Paid in Capital, Common StockUSD $717.76M; Treasury Stock, Common, ValueUSD $505.76M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $277.00K.
- 2025-12-31: Common Stock, Value, IssuedUSD $9.00K; Additional Paid in Capital, Common StockUSD $700.78M; Treasury Stock, Common, ValueUSD $388.07M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $498.00K.
- 2025-09-30: Common Stock, Value, IssuedUSD $9.00K; Additional Paid in Capital, Common StockUSD $673.12M; Treasury Stock, Common, ValueUSD $303.89M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $419.00K.
Progyny, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.00K | $735.42M | $537.52M | $245.00K | $255.11M | $453.26M | 23.00M | 3 month · $21.18M 6 month · $41.53M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $9.00K | $717.76M | $505.76M | $277.00K | $227.06M | $439.34M | 21.81M | 3 month · $20.36M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $9.00K | $700.78M | $388.07M | $498.00K | $202.83M | $516.04M | 16.30M | 12 month · $134.63M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $9.00K | $673.12M | $303.89M | $419.00K | $190.34M | $560.00M | 13.00M | 3 month · $33.02M 9 month · $99.10M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $9.00K | $642.21M | $303.89M | $218.00K | $176.48M | $515.02M | 13.00M | 3 month · $33.07M 6 month · $66.08M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $9.00K | $611.56M | $303.89M | $110.00K | $159.37M | $467.16M | 13.00M | 3 month · $33.01M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $9.00K | $581.60M | $303.89M | $39.00K | $144.31M | $422.06M | 13.00M | 12 month · $129.54M | 12 month · $7.31M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $9.00K | $551.59M | $250.82M | $330.00K | $133.78M | $434.88M | 9.75M | 3 month · $33.47M 9 month · $98.00M | 3 month · $-2.19M 9 month · $-7.31M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $9.00K | $519.67M | $188.87M | $2.02M | $123.35M | $456.19M | 6.93M | 3 month · $33.32M 6 month · $64.53M | 3 month · $-2.63M 6 month · $-5.12M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $9.00K | $489.34M | $27.37M | $2.75M | $106.87M | $571.60M | 1.34M | 3 month · $31.21M | 3 month · $-2.49M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $9.00K | $461.64M | $1.01M | $2.82M | $89.97M | $553.43M | 615.98K | 12 month · $123.21M | 12 month · $3.81M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $9.00K | $438.04M | $1.01M | $1.85M | $76.50M | $515.39M | 615.98K | 3 month · $31.41M 9 month · $94.25M | 3 month · $-1.38M 9 month · $-2.70M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $9.00K | $408.81M | $1.01M | $1.08M | $60.60M | $469.50M | 615.98K | 3 month · $31.90M 6 month · $62.85M | 3 month · $-822.00K 6 month · $-1.32M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $9.00K | $379.06M | $1.01M | $724.00K | $45.61M | $424.40M | 615.98K | 3 month · $30.95M | 3 month · $-502.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $9.00K | $349.53M | $1.01M | $501.00K | $27.93M | $376.97M | 615.98K | 12 month · $101.52M | 12 month · $295.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $9.00K | $323.12M | $1.01M | $205.00K | $24.53M | $346.86M | 615.98K | 3 month · $23.42M 9 month · $71.94M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $9.00K | $300.69M | $1.01M | $18.00K | $11.31M | $311.02M | 615.98K | 3 month · $23.82M 6 month · $48.52M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $9.00K | $278.08M | $1.01M | $-11.00K | $2.55M | $279.62M | 615.98K | 3 month · $24.70M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $9.00K | $255.34M | $1.01M | $-93.00K | $-2.42M | $251.82M | 615.98K | 12 month · $33.79M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $9.00K | $242.93M | $1.01M | $-312.00K | $-17.50M | $224.11M | 615.98K | 3 month · $7.18M 9 month · $18.74M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $9.00K | $240.11M | $1.01M | $-270.00K | $-34.30M | $204.54M | 615.98K | 3 month · $6.53M 6 month · $11.56M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $9.00K | $238.69M | $1.01M | $-50.00K | $-53.03M | $184.62M | 615.98K | 3 month · $5.03M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $9.00K | $236.14M | $1.01M | $1.00K | $-68.19M | $166.95M | 615.98K | 12 month · $12.82M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $9.00K | $234.13M | $1.01M | $17.00K | $-105.88M | $125.89M | 615.98K | 3 month · $3.07M 9 month · $8.66M | (m) | (m) | 3 month · $101.00K | (m) | (m) | (m) |
| 2020-06-30 | $9.00K | $231.79M | $1.01M | $5.00K | $-111.24M | $118.71M | 615.98K | 3 month · $3.54M 6 month · $5.59M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $8.00K | $231.52M | $1.01M | (m) | $-109.43M | $119.49M | 615.98K | 3 month · $2.05M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $8.00K | $228.75M | $1.01M | (m) | $-113.48M | $114.27M | 615.98K | 12 month · $5.06M | (m) | 12 month · $185.00K | (m) | 12 month · $22.77M | (m) | (m) |
| 2019-09-30 | $1.00K | $18.84M | $1.01M | (m) | $-109.08M | $-91.25M | 615.98K | 3 month · $1.68M 9 month · $3.21M | (m) | 3 month · $182.00K 9 month · $182.00K | (m) | (m) | (m) | (m) |
| 2019-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 26.66K | 1 month · 6.91 |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $-89.51M | (m) | 3 month · $1.01M 6 month · $1.53M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $-92.08M | (m) | 3 month · $517.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $1.00K | $10.62M | $884.00K | (m) | $-104.85M | $-95.11M | 589.32K | 12 month · $3.00M | (m) | 12 month · $1.21M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | $-94.30M | (m) | 3 month · $796.00K 9 month · $2.30M | (m) | 1 month · $1.20M 3 month · $1.21M 9 month · $1.21M | (m) | (m) | 1 month · 589.32K | 1 month · 2.04 |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | $-92.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | $-97.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |